Read + Share
Drake MJ, Birder LA. Re: EV-301 Long-term Outcomes: 24-month Findings from the Phase III Trial of
Enfortumab Vedotin Versus Chemotherapy in Patients with Previously Treated
Advanced Urothelial Carcinoma. Eur Urol 2024;86:183-184.
PMID: 38538426
|
 |
|
